EUROPEAN JOURNAL OF
PHARMACEUTICAL AND MEDICAL RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE  , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , 

 ISSN 2394-3211

Impact Factor: 6.222

 ICV - 79.57

Abstract

MOLECULAR STUDIES ON SELENIUM NANOPARTICLES IN DIABETES

Sayadat S. Abd- EL Maged, Doaa M. Abd-EL Fattah and Aya A. El Sobky*

ABSTRACT

The fundamental characteristic of selenium nanoparticles have given it a great priority to the attention of scientists and researchers, particularly in their medical applications, selenium nanoparticles identified as an antioxidant and also to protect the body and get rid of the harmful damage of free molecules resulting from oxygen metabolism, A vital and important role where it has been proven in a laboratory that it shields the body from the danger from the risk of heart illness, diabetes and cancer tumors. Therefore, this study was concerned the possible protective effect of CTS-SeNPs and Actozone drug in Sprague Dawely male rats. The experiment was applied on fifty Sprague Dawely male rats (140-160 gm) were prepared for this experiment. They were brought from Laboratory Animal Farm of the Faculty of Veterinary Medicine, Zagazig University. Results revealed that CTS-SeNPs + Actozone group had the highest body weight than other groups. Diabetic group revealed the highest glucose, liver enzymes activities, lipid profile and G6PD values and group treated with CTS-SeNPs showed significant decrease in values compared to the diabetic group. Diabetic group was the lowest insulin reading, total protein, albumin, globulin, hepatic oxidant/antioxidant, Pdx1 and Ngn3 genes levels and group treated with CTS-SeNPs showed significant increase in values compared to the diabetic group. Histopathological examination of all liver & pancreas specimens diabetic treated with CTS_SeNPs + actozone group; liver & pancreas of rat showed almost normal histological picture except for mild vascular congestion. In conclusion the results of this investigation demonstrated that DM-induced severe biochemical and histopathological changes in the liver and pancreas and CTS-SeNPs have a protective effect and minimize the risk of diabetic complications.

Keywords: Diabetes Mellitus, CTS-SeNPs, Actozone, Streptozotocin.


[Full Text Article]

INDEXING

NEWS & UPDATION

  • New Issue Published

    Its Our pleasure to inform you that, EJPMR 1 June 2021 Issue has been Published, Kindly check it on http://www.ejpmr.com/home/current_issues

  • EJPMR: JUNE ISSUE PUBLISHED

    JUNE Issue has been successfully launched on 1 June 2021.

  • EJPMR New Impact Factor

    Its our Pleasure to Inform you that EJPMR Impact Factor has been increased from  5.804 to 6.222, due to high quality Publication at International Level

  • Index Copernicus Value

    EJPMR Received Index Copernicus Value 79.57, due to High Quality Publication in EJPMR at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Article are invited for publication in EJPMR Coming Issue

Google Scholar Indian Science Publications InfoBase Index (In Process) SOCOLAR, China Research Bible, Fuchu, Tokyo. JAPAN International Society for Research activity (ISRA) Scientific Indexing Services (SIS) Polish Scholarly Bibliography Global Impact Factor (GIF) (Under Process) Universal Impact Factor International Scientific Indexing (ISI), UAE Index Copernicus CAS (A Division of American Chemical Society) USA (Under Process) Directory of Open Access Journal (DOAJ, Sweden, in process) UDLedge Science Citation Index CiteFactor Directory Of Research Journal Indexing (DRJI) Indian citation Index (ICI) Journal Index (JI, Under Process) Directory of abstract indexing for Journals (DAIJ) Open Access Journals (Under Process) Impact Factor Services For International Journals (IFSIJ) Cosmos Impact Factor Jour Informatics (Under Process) Eurasian Scientific Journal Index (ESJI) International Innovative Journal Impact Factor (IIJIF) Science Library Index, Dubai, United Arab Emirates Pubmed Database [NLM ID: 101669306] (Under Process) IP Indexing (IP Value 2.40) Web of Science Group (Under Process) Directory of Research Journals Indexing Scholar Article Journal Index (SAJI) International Scientific Indexing ( ISI )